the Effect of intraperitoneal Bupivacaine in pain reduce

the Effect of intraperitoneal Bupivacaine in comparison with Dexmedetomidine with Bupivacaine Spray on pain reduction after laparoscopic Endometrial Surgery, A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150817023666N11

Enrollment

Registered

2018-04-09

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Endometriosis of uterus

Interventions

Intervention 1: First group: intra peritonal bupivacaein spray ( 50 cc 0.25%) this intervention will be performed at the end of the procedure. Intervention 2: second group: intraperitonal bupivacaei

Eligibility

Sex/Gender

Female

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Informed consent to enter the study Candidate for laparoscopic surgery due to benign gynecological disease Age between 20 and 65 years Patients ASA I, II women with endometriosis

Exclusion criteria

Exclusion criteria: Patients who have not signed the consent form Patients whose laparoscopic surgery has changed to vaginal or abdominal Patients that underwent surgery without general anesthesia Pregnant women Allergy to local anesthetics or Dexmedetomidine Patients with morbid obesity Patients with liver or kidney failure

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: before surgery and 2,4 ,6 ,12 and 24 Hour after surgery. Method of measurement: Visual analog score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Najmi

Iran University of Medical Sciences

amehdizadehkashi@yahoo.com+98 21 6650 9283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026